Renal Arteries Embolization in Unresectable Clear Cell Renal Carcinoma: First Time Experience at Haji Adam Malik Hospital

• Published in: Open access Macedonian journal of medical sciences 2018-08, Vol.6 (8), p.1454-1457
• Main Authors: Perdana, Noor Riza, Daulay, Elvita Rahmi, Prapiska, Fauriski Febrian
• Format: Article
• Language: English
• Subjects: Case Report
• ISSN: 1857-9655; 1857-9655
• DOI: 10.3889/oamjms.2018.282

To report a case of renal arterial embolisation (RAE) in unresectable renal tumour before nephrectomy. On presentation, the clinical features of this patient, including medical history, signs and symptoms, imaging examinations were recorded. After diagnosis and initial treatment, the result and histopathological examination were performed and discussed. We performed RAE in the unresectable renal tumour in the 28-year-old male that was complaining a palpable pain right flank mass and intermittent hematuria that had been observed five months earlier. A month after RAE, the tumour shrinks and become resectable. The parameter used was tumour volume, propulsion and component, with subjective value VAS, hematuria symptom and Quality Of Life Score EORTC-QLQ C30. The next step we performed nephrectomy with histopathology results in Clear Cell Renal Carcinoma (CCRC). RAE is an effective therapeutic and adjuvant tool because it facilitates the dissection of unresectable large renal tumours and tumours with extensive involvement around the renal hilum; it leading to lower overall morbidity. However, the lack of randomised prospective studies is the primary reason that RAE is not used often before surgery.